CL

Calidi Biotherapeutics IncNYSE-MKT CLDI Stock Report

Last reporting period 31 Dec, 2023

Updated 21 Nov, 2024

Last price

Market cap $B

0.009

Micro

Exchange

XASE - Nyse MKT LLC

View Section: Price ratios

Calidi Statements

CL

Data from Calidi`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

31 Dec, 2023

Next reporting period:

30 Mar, 2024

Report frequency:

Quarterly

Earnings release date:

Expected release date:

Calidi Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-12-31
%

100

0

0

3.958

0

5.862

0

9.82

36 %

0

-9.82

-36 %

0

-0.222

0

1.81

0

-8.232

-308.9 %

0

-0.003

0

-8.229

-306.6 %

0

-1.537

5.354

2023-09-30
%

100

0

0

3.251

0

3.97

0

7.221

10.5 %

0

-7.221

-10.5 %

0

-0.324

0

6.003

0

-2.013

83.9 %

0

0.011

0

-2.024

83.8 %

0

-0.445

4.545

2023-06-30
%

100

0

0

3.177

0

3.36

0

6.537

20.7 %

0

-6.537

-20.7 %

0

-0.306

0

-5.654

0

-12.497

-93.5 %

0

0.004

0

-12.501

-93.5 %

0

-2.75

4.545

2023-03-31
%

100

0

0

2.622

0

2.792

0

5.414

99.4 %

0

-5.414

-99.4 %

0

-0.217

0

-0.827

0

-6.458

-164.3 %

0

0.004

0

-6.462

-149.8 %

0

-0.142

45.452

2022-12-31
%

100

0

0

0

2.715

0

2.715

0

-2.715

0

0.131

0

0.14

0

-2.443

0

0.143

0

-2.587

0

-0.262

9.878

View Section: Balance Sheet